<code id='60E9869AF8'></code><style id='60E9869AF8'></style>
    • <acronym id='60E9869AF8'></acronym>
      <center id='60E9869AF8'><center id='60E9869AF8'><tfoot id='60E9869AF8'></tfoot></center><abbr id='60E9869AF8'><dir id='60E9869AF8'><tfoot id='60E9869AF8'></tfoot><noframes id='60E9869AF8'>

    • <optgroup id='60E9869AF8'><strike id='60E9869AF8'><sup id='60E9869AF8'></sup></strike><code id='60E9869AF8'></code></optgroup>
        1. <b id='60E9869AF8'><label id='60E9869AF8'><select id='60E9869AF8'><dt id='60E9869AF8'><span id='60E9869AF8'></span></dt></select></label></b><u id='60E9869AF8'></u>
          <i id='60E9869AF8'><strike id='60E9869AF8'><tt id='60E9869AF8'><pre id='60E9869AF8'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:415
          Adobe

          Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial. 

          The negative outcome of the Phase 3 study represents a setback in the company’s efforts to expand the use of Nuplazid into the treatment of schizophrenia. The medicine is currently approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

          advertisement

          “We are disappointed the trial did not meet its primary endpoint given the significant unmet need in patients with negative symptoms of schizophrenia,” said Acadia CEO Steve Davis, in a statement. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          STAT readers on older presidents, polypills, Medicare, and more
          STAT readers on older presidents, polypills, Medicare, and more

          MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          H5N1 bird flu virus started spreading in cows in Texas in December

          ColorizedmicroscopicimageofH5N1birdfluvirusparticles(inyellow).NIAIDAsagriculturalauthoritiesandepid